Increasing antibody yield and modulating final product quality using the Freedom(TM) CHO-S(TM) production platform
BMC Proc
.
2011 Nov 22;5 Suppl 8(Suppl 8):P102.
doi: 10.1186/1753-6561-5-S8-P102.
eCollection 2011.
Authors
Michelle Sabourin
1
,
Ying Huang
1
,
Prasad Dhulipala
2
,
Shannon Beatty
1
,
Jian Liu
1
,
Peter Slade
3
,
Shawn Barrett
2
,
Shue-Yuan Wang
1
,
Karsten Winkler
4
,
Susanne Seitz
4
,
Thomas Rose
4
,
Volker Sandig
4
,
Peggy Lio
1
,
Steve Gorfien
2
,
Laurie Donahue-Hjelle
2
,
Graziella Piras
1
Affiliations
1
Life TechnologiesTM, Frederick, MD, 21704, USA.
2
Life TechnologiesTM, Grand Island, NY, 14072, USA.
3
Life TechnologiesTM, Eugene, OR, 97402, USA.
4
ProBioGen AG, Goethestrasse 54, 13086 Berlin, Germany.
PMID:
22373027
PMCID:
PMC3284927
DOI:
10.1186/1753-6561-5-S8-P102
No abstract available